6 completed, 1 not yet recruiting, 1 terminated, 1 unknown. 6 Phase 3, 2 Phase 1, 2 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 5, Not yet recruiting 1 |
| Phase 1 | 2 | Terminated 1, Unknown 1 |
| Phase 2 | 2 | Not yet recruiting 1, Terminated 1 |
| Phase 4 | 1 | Completed 1 |
Follow Epoetin: new trials by email Literature Review of Epoetin trials Research Report on Epoetin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Luspatercept vs Epoetin in Treating Poor Erythroid Engraftment for Hematological Malignancies Luspatercept, Epoetin - Luspatercept, Epoetin | Phase 2 / Phase 3 | Not yet recruiting | Nanfang Hospital, Southern Medical University | 90 | 2026-06-15 | 2026-06-09 |
| EPOgen and Restrictive Transfusions in Patients Undergoing Cardiac Surgery (EPORT) Epogen, Normal Saline - Cardiac Surgery-CABG, Cardiac Valve Replacement | Phase 1 / Phase 2 | Terminated | Johns Hopkins University | 4 | 2015-05-01 | 2019-02-26 |
| Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on Dialysis Epoetin, Peginesatide - Chronic Kidney Disease, Anemia | Phase 3 | Completed | Takeda | 184 | 2011-10-01 | 2016-09-20 |
| A Study of Intravenous Mircera for the Correction of Anemia in Dialysis Patients. methoxy polyethylene glycol-epoetin beta [RO0503821, Mircera], Epoetin - Anemia | Phase 3 | Completed | Hoffmann-La Roche | 80 | 2007-11-01 | 2016-09-19 |
| Correction of Anaemia and Progression of Renal Failure on Transplanted Patients Neorecormon - Anaemia, Renal Transplantation | Phase 4 | Completed | Centre Hospitalier Universitaire, Amiens | 128 | 2004-04-01 | 2025-09-23 |
| A Study of Mircera for the Treatment of Anemia in Dialysis Patients epoetin, methoxy polyethylene glycol-epoetin beta [Mircera] - Anemia | Phase 3 | Completed | Hoffmann-La Roche | 182 | 2004-02-01 | 2016-11-02 |
| A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients Epoetin alfa or beta, RO0503821 (1x/2 Weeks), RO0503821 (1x/4 Weeks) - Anemia | Phase 3 | Completed | Hoffmann-La Roche | 673 | 2004-02-01 | 2017-01-13 |
| Comparison of Epoetin Alfa and Epoetin Omega in Anemic Dialysis Patients:Results of Efficacy Trial Epoetin - End Stage Renal Disease, Renal Anemia | Phase 3 | Completed | General Hospital Sveti Duh | 80 | 1997-01-01 | 2006-07-21 |
| Erythropoietin for Infants With Brain Injuries Due to Oxygen Deprivation at Birth epoetin - Asphyxia | Phase 1 | Unknown | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 15 | 2007-06-26 |
Anemia (5) · Kidney Failure, Chronic (2) · Asphyxia (1) · Hematologic Neoplasms (1) · Renal Insufficiency (1) · Renal Insufficiency, Chronic (1)
Hoffmann-La Roche (3) · Centre Hospitalier Universitaire, Amiens (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · General Hospital Sveti Duh (1) · Johns Hopkins University (1) · Nanfang Hospital, Southern Medical University (1) · Takeda (1)
United States (5) · Canada (2) · France (2) · Norway (2) · Spain (2) · Switzerland (2) · Brazil (1) · China (1) · Croatia (1) · Czechia (1) · Germany (1) · Greece (1) · Italy (1) · Poland (1) · Russia (1)
Franck Martinez, MD, PhD (1) · Gabriel Choukroun, MD, PhD (1) · Keith A. Horvath, MD (1) · Qifa Liu (1) · Robert D. Christensen, MD (1) · Slobodan Milutinovic, M.D., Ph.D. (1)
PMID 36791280, PMID 16758521, PMID 17950856, PMID 18037099, PMID 22193388, PMID 24431909